Pyrazine carbamates and their use as GluN2B receptor modulators | Patent Number 11459336

US 11459336 B2
Application Number16899817
Publication NumberUS 20200392155 A1
Pendency2 years, 3 months, 24 days
Filled DateJun 12, 2020
Priority DateJun 14, 2019
Publication DateDec 17, 2020
Expiration DateJun 13, 2039
Inventor/ApplicantsChristine GELIN
Christine Gelin
ExaminesHAVLIN, ROBERT H
Art Unit1639
Technology Center1600
Assignments
Janssen Pharmaceuticals Johnson & Johnson
Current
Janssen Pharmaceuticals Johnson & JohnsonJohnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.